TACI/TNFRSF13B hFc Chimera, Human
| $340.00 | |
| Z05861-100 | |
|
|
|
|
|
|
|
|
|
| Ask us a question | |
IVD Raw Materials
| $340.00 | |
| Z05861-100 | |
|
|
|
|
|
|
|
|
|
| Ask us a question | |
| Species | Human | ||||
| Protein Construction |
|
||||
| Purity | > 95% as determined by BisTris PAGE | ||||
| Endotoxin Level | Less than 1EU per μg by the LAL method. | ||||
| Biological Activity | Measured by its binding ability in a functional ELISA. Test result was comparable to standard batch. | ||||
| Expression System | HEK293 | ||||
| Theoretical Molecular Weight | 45.3 kDa | ||||
| Apparent Molecular Weight | Due to glycosylation, the protein migrates to 38-40 kDa and 50-55 kDa based on Bis-Tris PAGE result. | ||||
| Formulation | Lyophilized from 0.22μm filtered solution in PBS (pH 7.4). | ||||
| Reconstitution | Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water. | ||||
| Storage & Stability | Upon receiving, the product remains stable for 6 months at -20℃ or below. Upon reconstitution, the product should be stable for 3 months at -80℃. Avoid repeated freeze-thaw cycles. |
Immobilized Human BAFF (Trimer), His Tag at 2 μg/ml (100 μl/well) on the plate. Dose response curve for TACI/TNFRSF13B hFc Chimera, Human, hFc Tag with the EC50 of 3.5ng/ml determined by ELISA. »
The purity of TACI/TNFRSF13B hFc Chimera, Human is greater than 95% as determined by SEC-HPLC. »
TACI/TNFRSF13B hFc Chimera, Human on Bis-Tris PAGE under reduced condition. The purity is greater than 95%. »
| Target Background | Transmembrane activator and calcium-modulating cyclophilin ligand interactor (TACI) is one of the receptors of B cell activating factor of the tumor necrosis factor family (BAFF) and a proliferation-inducing ligand (APRIL). TACI is a regulator in the immune responses. TACI inhibits B cell expansion and promotes the differentiation and survival of plasma cells. |
| Synonyms | CD267; TNFRSF13B; TACI; CVID; CVID2; IGAD2; RYZN; TACI |
For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.